Novartis | Resultat Før Skatt

Pre Tax Profit Endring Dato
AbbVie USD 1.76B 4.24B 2024-03
Amgen USD -68000000 3.09B 2024-03
AstraZeneca USD 2.8B 385M 2024-03
Bausch Health Companies USD -69000000 532M 2024-03
Biogen USD 464.8M 336.9M 2024-03
Bristol-Myers Squibb USD -11516000000 15.59B 2024-03
Canopy Growth CAD -96110000 135.24M 2024-03
Catalent USD -86000000 56M 2024-03
Corcept Therapeutics USD 34.99M 1.82M 2024-03
Eli Lilly USD 2.54B 52.4M 2024-03
Gilead Sciences USD -4486000000 7.08B 2024-03
GlaxoSmithKline GBP 1.36B 549M 2024-03
Glaxosmithkline USD 1.36B 581.39M 2024-03
J&J USD 3.71B 2.52B 2024-03
Merck USD 5.67B 6.14B 2024-03
Novartis USD 3.13B 606M 2024-03
Novartis USD 3.13B 606M 2024-03
Pacira USD 13.64M 34.51M 2024-03
Perrigo USD -98600000 206.2M 2024-03
Pfizer USD 3.42B 4.67B 2024-03
Prestige Brands USD 67.32M 2.25M 2024-03
Roche Holding CHF 10.33B 1.48B 2023-06
Sanofi EUR 1.35B 2.61B 2024-03
Sanofi USD 1.35B 2.96B 2024-03
Supernus Pharmaceuticals USD 243K 747K 2024-03
Zoetis USD 747M 49M 2024-03



Novartis Resultat Før Skatt - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.